Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E

Atherosclerosis

Volumn 140, Issue 2, 1998, Pages 333-339

  Ribeiro Jorge, Paulo Afonso ^a   Cruz Neyra, Lidia ^a   Michiko Ozaki, Regina ^a   De Almeida, Eros ^a  

^a Rua Guilherme Da Silva   (Brazil)

Author keywords

Endothelium dependent relaxation; Hypercholesterolemia; Malondialdehyde (MDA); Native LDL; Oxidized LDL; Rabbits; Vitamin E

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; CHOLESTEROL; COCONUT OIL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY DILATATION; ARTERY WALL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CHOLESTEROL; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FOLLOW-UP STUDIES; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; RABBITS; RANDOM ALLOCATION; VASODILATION; VITAMIN E;

EID: 0031759923     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00137-3     Document Type: Article

References (40)

1. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
2. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. New Engl J Med. 320:1989;915-923.
3. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation. 85:1992;1927-1938.
4. Mangin E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 72:1993;161-166.
5. Shimokawa H., Flavahan N.A., Vanhoutte P.M. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation. 83:1991;652-660.
6. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherosclerosis. Proc Natl Acad Sci USA. 84:1987;2995-2998.
7. Brown G., Albers J.J., Fisher L.D., Schaefer S.M., Lin J.T., Kaplan C., Zhao X.Q., Bisson B.D., Fitzpatrick V.F., Dodge H.T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. New Engl J Med. 323:1990;1289-1298.
8. Blankenhorn D.H., Nessim S.A., Johnson R.L., Sanmarco M.E., Azen S.P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Coll Cardiol. 23:1987;3233-3240.
9. Mugge A., Elwelll J.H., Peterson T.E., Hofmayer T.G., Heistad D.D., Harrison D.G. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol fed-rabbits. Circ Res. 69:1991;1293-1300.
10. Carew T.E., Schwenke D.C., Steinberg D. Anti-atherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein in macrophages rich fatty streaks and slow the progression of atherosclerosis in WHHL rabbit. Proc Natl Acad Sci USA. 84:1987;7725-7729.
11. Rim E.B., Stampfer M.J., Aschiero A., Giovannucci E., Coldits G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med. 328:1993;1450-1456.
12. Gey K.F., Puska P., Jordan P., Moser V.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 53:1991;326S-334S.
13. Belcher J.B., Balla J., Balla G., Jacobs D.R., Gross M., Jacob H.S., Vercellotti G.M. Vitamin E, LDL and endothelium. Arterioscler Thromb. 13:1993;1779-1784.
14. Jessup W., Rankin S.M., De Whalley C.V., Hoult J.R.S., Scott J., Leake D.S. Alfa-tocopherol consumption during low density-lipoprotein oxidation. Biochem J. 265:1990;399-405.
15. Moncada S., Radomski M.W., Palmer R.M. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol. 37:1988;2495-2501.
16. Garg U.C., Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
17. Warnick R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 129:1986;101-123.
18. Naito HK, David JA. Laboratory considerations: determination of cholesterol, triglycerides, phospholipids and other lipids in blood and tissues. In: Laboratory and Research Methods in Biology and Medicine: Lipid Research Methodology. New York: Alan R. Liss, 1981:1-76.
19. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497-509.
20. Cassini A.F., Ferrali M., Pompella A., Maellaro E., Comporti M. Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene-intoxicated mice. Am J Pathol. 123:1986;520-531.
21. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.L. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
23. Parthasarathy S., Khoo J.C., Miller E., Barnett J., Witztum J., Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modifications: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA. 87:1990;3894-3898.
24. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
25. SAS (Statistical Analysis System). SAS/TAT User's Guide, version 6, 4th ed, vol 1, 1990.
26. Box GE, Hunter WG, Hunter JS. Statistics for Experimenters. An Introduction to Design Data Analysis and Model Building. New York: John Wiley & Sons, 1983.
27. Quiao Y., Yokoyama M., Kameyama K., Assano G. Effect of vitamin E on vascular integrity in cholesterol-fed guinea pigs. Arterioscler Thromb. 13:1993;1885-1892.
28. Stewart-Lee A.L., Forster L.A., Nouroo-Zadeh J., Ferns G.A.A., Angaard E.E. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb. 14:1994;494-499.
29. Ribeiro Jorge P.A., Osaki R.M., Ameida E., Credidio L., Metze K. Effects of vitamin E on endothelium-dependent coronary flow in hypercholesterolemic dogs. Atherosclerosis. 126:1996;43-51.
30. Keaney J.F. Jr., Gaziano J.M., Xu A., Frei B., Curran-Celentano J., Shaery G.T., Loscalzo J., Vita J.A. Low-dose alfa-tocoferol improves and high dose alfa-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 93:1994;844-851.
31. Gilligan DM, Sack MN, Guetta V, Casino PR, Rader DJ, Quyyumi AA, FAAC, Panza JA, Canon III RO. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611-1617.
32. Ribeiro Jorge P.A., Ozki R.M., Almeida E. Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin. Clin Exp Pharmacol Physiol. 24:1997;948-953.
33. Hoffman R., Brook G.J., Aviram M. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis. 93:1992;105-113.
34. Traber G.M., Kayden H.J. Alfa-tocopherol as compared with gama-tocopherol is preferentially secreted in human lipoproteins. Ann New York Acad Sci. 570:1989;95-107.
35. Qureshi A., Burger W., Peterson D., Elson C.H. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem. 261:1986;1054-1063.
36. Berglund L., Sharkey M., Elam R., Witztum J. Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism. J Lipid Res. 30:1989;1591-1600.
37. Pauyl J., Bai N.J., Devi G.L. The effect of vitamin E on lipid components of atherogenic rats. Int J Vit Nutr Res. 59:1989;35-39.
38. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport (review). J Lipid Res. 36:1995;211-228.
39. Rothblat G.E., Mahlberg F.H., Johnson W.J., Phillips M.C. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res. 33:1992;1091-1097.
40. Oram J.F. Cholesterol trafficking in cells. Curr Opin Lipidol. 1:1990;416-421.